Ferrous sulfate is a mineral required by the body to make red blood cells. Iron deficiency can result in fatigue, shortness of breath, and impaired physical performance which can also increase the likelihood of infection in a liver transplant recipient. Ferrous sulfate appears to be a relatively popular drug used to treat iron deficiency anemia. It is available as a generic drug and is often used in combination with other iron supplements.
The global Ferrous Sulfate Market was valued at USD 842.62 million in 2022 and is projected to reach USD 1,069.41 million by 2030, growing at a CAGR of 3.09% from 2023 to 2030.